1646P A multicohort phase II trial of androgen deprivation therapy (ADT), docetaxel (DOCE) and nivolumab (NIVO) in patients (pts) with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) enriched for inflamed tumours and DNA damage repair (DDR) alterations: Cohort 3 results
| Autor: | Wei, X.X., Chahoud, J., Emamekhoo, H., McKay, R.R., Marshall, C.H., Einstein, D., Lang, J.M., Raymond, S., Roberts, D.A., Ravi, P., Tewari, A., Pomerantz, M., Dong, F., Siegmund, S., Rodig, S., Sweeney, C., Taplin, M.E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S992-S993 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|